Health Care Select Sector SPDR
XLV----
Health Care Select Sector SPDR (XLV)
XLV tracks health care stocks from within the S&P 500 Index, weighted by market cap.
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
News
- PUBT · 56 minutes ago
Genmab, AbbVie clarify primary endpoints in Phase 3 EPCORE DLBCL-1 trial
- GuruFocus · 3 hours ago
Lilly Targets Early 2027 Filing for Next Obesity Drug
- rttnews · 9 hours ago
Eli Lilly's Retatrutide Meets Primary Endpoint In Phase 3 TRIUMPH-2 And TRIUMPH-3 Trials
- rttnews · 7 hours ago
J&J Says TECVAYLI+TALVEY Cuts Risk Of Disease Progression Or Death By 89% In Multiple Myeloma Trial
- PUBT · 8 hours ago
Johnson & Johnson posts press release on MonumenTAL-6 multiple myeloma trial results
- CNBC · 10 hours ago
Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials
